Kane Biotech

TURNING NOVEL DISCOVERIES INTO
INNOVATIVE HEALTH CARE SOLUTIONS.

KANE BIOTECH INC. is a biotechnology company engaged in the development of products to prevent and disperse biofilms. Biofilms are a major cause of a number of serious medical problems including chronic infections and medical device related infections. They develop on surfaces such as catheters, prosthetic implants, teeth, lungs and the urogenital tract. Biofilms are pervasive, costly to deal with and approximately 80% of all human bacterial infections involve biofilms. The healing of chronic wounds alone costs the United States health care system $20 billion per year.

News

January 17, 2012:Kane Biotech Renews Investor Relations Agreement With Pure... Read more...

December 15, 2011:Kane Biotech submits Supplemental Data on KBI Disinfectant to Health Canada Read more...

December 12, 2011:Kane Biotech Announces Appointment of Mark Matthewson as New CFO Read more...

Products

DispersinB® is an antibiofilm enzyme, which inhibits and disperses biofilms of major bacterial pathogens. Read more...

Kane Biotech has developed a broad-spectrum anti-infective composition Aledex® (formerly called PS/CHX) Read more...

CSP is an oral care additive for preventing and dispersing dental plaque biofilms. Read more...

What's New

Read more about Kane's latest product - KBI Antibacterial Disinfectant (KBI).KBI contains a unique, patented, antimicrobial-antibiofilm combination comprised of Chlorhexidine (CHX) and Sodium Metaperiodate (SMP).